nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—Cytochrome P450 3A4 Inhibitors—Colchicine—primary biliary cirrhosis	0.777	1	CiPCiCtD
Everolimus—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.0451	0.664	CbGbCtD
Everolimus—CYP3A4—Colchicine—primary biliary cirrhosis	0.0228	0.336	CbGbCtD
Everolimus—MTOR—mTORC1-mediated signalling—RPS6KB1—primary biliary cirrhosis	0.000931	0.018	CbGpPWpGaD
Everolimus—MTOR—CXCR3-mediated signaling events—CXCL9—primary biliary cirrhosis	0.000795	0.0153	CbGpPWpGaD
Everolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—CD40LG—primary biliary cirrhosis	0.000784	0.0151	CbGpPWpGaD
Everolimus—MTOR—SREBF and miR33 in cholesterol and lipid homeostasis—PPARGC1A—primary biliary cirrhosis	0.000765	0.0147	CbGpPWpGaD
Everolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—IL4—primary biliary cirrhosis	0.000763	0.0147	CbGpPWpGaD
Everolimus—MTOR—TSLP Signaling Pathway—IL7R—primary biliary cirrhosis	0.000753	0.0145	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta receptor signaling—CTGF—primary biliary cirrhosis	0.000696	0.0134	CbGpPWpGaD
Everolimus—MTOR—IL12-mediated signaling events—CD3D—primary biliary cirrhosis	0.000674	0.013	CbGpPWpGaD
Everolimus—FKBP1A—TOR Signaling—RPS6KB1—primary biliary cirrhosis	0.000641	0.0124	CbGpPWpGaD
Everolimus—CYP3A4—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.000636	0.0123	CbGpPWpGaD
Everolimus—MTOR—Cardiac Hypertrophic Response—MAP3K14—primary biliary cirrhosis	0.000629	0.0121	CbGpPWpGaD
Everolimus—MTOR—Costimulation by the CD28 family—CD3D—primary biliary cirrhosis	0.000609	0.0118	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta receptor signaling—TAB1—primary biliary cirrhosis	0.000592	0.0114	CbGpPWpGaD
Everolimus—MTOR—ErbB1 downstream signaling—RPS6KA4—primary biliary cirrhosis	0.000582	0.0112	CbGpPWpGaD
Everolimus—MTOR—IL12-mediated signaling events—IL12A—primary biliary cirrhosis	0.000537	0.0103	CbGpPWpGaD
Everolimus—MTOR—Costimulation by the CD28 family—MAP3K14—primary biliary cirrhosis	0.000531	0.0102	CbGpPWpGaD
Everolimus—FKBP1A—Spinal Cord Injury—AQP4—primary biliary cirrhosis	0.000516	0.00996	CbGpPWpGaD
Everolimus—MTOR—CXCR4-mediated signaling events—CD3D—primary biliary cirrhosis	0.000515	0.00992	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000486	0.00937	CbGpPWpGaD
Everolimus—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—primary biliary cirrhosis	0.000485	0.00934	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta receptor signaling—RPS6KB1—primary biliary cirrhosis	0.000478	0.00922	CbGpPWpGaD
Everolimus—MTOR—FSH signaling pathway—RPS6KB1—primary biliary cirrhosis	0.000454	0.00876	CbGpPWpGaD
Everolimus—MTOR—mTOR signalling—RPS6KB1—primary biliary cirrhosis	0.000454	0.00876	CbGpPWpGaD
Everolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—MAP3K14—primary biliary cirrhosis	0.000448	0.00864	CbGpPWpGaD
Everolimus—MTOR—TSLP Signaling Pathway—STAT4—primary biliary cirrhosis	0.000448	0.00863	CbGpPWpGaD
Everolimus—MTOR—PKB-mediated events—RPS6KB1—primary biliary cirrhosis	0.000441	0.0085	CbGpPWpGaD
Everolimus—MTOR—CD28 dependent PI3K/Akt signaling—CD80—primary biliary cirrhosis	0.000425	0.00819	CbGpPWpGaD
Everolimus—MTOR—Insulin Signaling—RPS6KA4—primary biliary cirrhosis	0.000416	0.00801	CbGpPWpGaD
Everolimus—MTOR—CXCR3-mediated signaling events—CXCL10—primary biliary cirrhosis	0.000414	0.00799	CbGpPWpGaD
Everolimus—CYP3A4—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.000406	0.00784	CbGpPWpGaD
Everolimus—MTOR—Interferon type I signaling pathways—STAT4—primary biliary cirrhosis	0.000401	0.00772	CbGpPWpGaD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—CDH5—primary biliary cirrhosis	0.000397	0.00766	CbGpPWpGaD
Everolimus—Cardiac failure congestive—Chenodeoxycholic acid—primary biliary cirrhosis	0.000391	0.00385	CcSEcCtD
Everolimus—MTOR—Signaling by VEGF—CDH5—primary biliary cirrhosis	0.000375	0.00723	CbGpPWpGaD
Everolimus—Atrial fibrillation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000374	0.00369	CcSEcCtD
Everolimus—Atrial fibrillation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000374	0.00369	CcSEcCtD
Everolimus—Renal impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.000373	0.00367	CcSEcCtD
Everolimus—Renal impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.000373	0.00367	CcSEcCtD
Everolimus—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.00037	0.00364	CcSEcCtD
Everolimus—MTOR—IL12-mediated signaling events—STAT4—primary biliary cirrhosis	0.000368	0.0071	CbGpPWpGaD
Everolimus—MTOR—Oncostatin M Signaling Pathway—MMP13—primary biliary cirrhosis	0.000367	0.00708	CbGpPWpGaD
Everolimus—Dehydration—Colchicine—primary biliary cirrhosis	0.000367	0.00361	CcSEcCtD
Everolimus—Cardiac failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000363	0.00358	CcSEcCtD
Everolimus—Cardiac failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000363	0.00358	CcSEcCtD
Everolimus—MTOR—TOR Signaling—RPS6KB1—primary biliary cirrhosis	0.000361	0.00696	CbGpPWpGaD
Everolimus—Aspartate aminotransferase increased—Colchicine—primary biliary cirrhosis	0.000355	0.0035	CcSEcCtD
Everolimus—MTOR—IL2 signaling events mediated by PI3K—RPS6KB1—primary biliary cirrhosis	0.000353	0.0068	CbGpPWpGaD
Everolimus—Migraine—Chenodeoxycholic acid—primary biliary cirrhosis	0.000349	0.00344	CcSEcCtD
Everolimus—Migraine—Ursodeoxycholic acid—primary biliary cirrhosis	0.000349	0.00344	CcSEcCtD
Everolimus—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.000348	0.00343	CcSEcCtD
Everolimus—Muscular weakness—Colchicine—primary biliary cirrhosis	0.000348	0.00343	CcSEcCtD
Everolimus—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.000348	0.00671	CbGpPWpGaD
Everolimus—CYP3A4—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.000346	0.00666	CbGpPWpGaD
Everolimus—MTOR—Cardiac Hypertrophic Response—TNFRSF1A—primary biliary cirrhosis	0.000345	0.00665	CbGpPWpGaD
Everolimus—MTOR—IL4-mediated signaling events—COL1A1—primary biliary cirrhosis	0.000345	0.00665	CbGpPWpGaD
Everolimus—MTOR—IL12-mediated signaling events—IL12B—primary biliary cirrhosis	0.000337	0.0065	CbGpPWpGaD
Everolimus—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000332	0.00327	CcSEcCtD
Everolimus—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000332	0.00327	CcSEcCtD
Everolimus—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.00033	0.00325	CcSEcCtD
Everolimus—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.00033	0.00325	CcSEcCtD
Everolimus—MTOR—Integrated Breast Cancer Pathway—DAG1—primary biliary cirrhosis	0.00033	0.00636	CbGpPWpGaD
Everolimus—Liver function test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000327	0.00322	CcSEcCtD
Everolimus—Liver function test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000327	0.00322	CcSEcCtD
Everolimus—Pancytopenia—Colchicine—primary biliary cirrhosis	0.000324	0.00319	CcSEcCtD
Everolimus—Abdominal pain upper—Ursodeoxycholic acid—primary biliary cirrhosis	0.000324	0.00319	CcSEcCtD
Everolimus—Abdominal pain upper—Chenodeoxycholic acid—primary biliary cirrhosis	0.000324	0.00319	CcSEcCtD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—ELMO1—primary biliary cirrhosis	0.000321	0.0062	CbGpPWpGaD
Everolimus—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000321	0.00316	CcSEcCtD
Everolimus—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000321	0.00316	CcSEcCtD
Everolimus—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000319	0.00314	CcSEcCtD
Everolimus—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000319	0.00314	CcSEcCtD
Everolimus—Neutropenia—Colchicine—primary biliary cirrhosis	0.000319	0.00314	CcSEcCtD
Everolimus—MTOR—RANKL/RANK Signaling Pathway—TAB1—primary biliary cirrhosis	0.000318	0.00613	CbGpPWpGaD
Everolimus—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000314	0.00309	CcSEcCtD
Everolimus—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000314	0.00309	CcSEcCtD
Everolimus—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000313	0.00308	CcSEcCtD
Everolimus—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000313	0.00308	CcSEcCtD
Everolimus—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000307	0.00302	CcSEcCtD
Everolimus—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.000307	0.00302	CcSEcCtD
Everolimus—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.000307	0.00302	CcSEcCtD
Everolimus—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000307	0.00302	CcSEcCtD
Everolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000304	0.00586	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—ELMO1—primary biliary cirrhosis	0.000303	0.00585	CbGpPWpGaD
Everolimus—MTOR—CD28 co-stimulation—CD80—primary biliary cirrhosis	0.000303	0.00584	CbGpPWpGaD
Everolimus—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000301	0.00296	CcSEcCtD
Everolimus—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000301	0.00296	CcSEcCtD
Everolimus—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.000299	0.00294	CcSEcCtD
Everolimus—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.000299	0.00294	CcSEcCtD
Everolimus—FKBP1A—Spinal Cord Injury—CXCL10—primary biliary cirrhosis	0.000297	0.00574	CbGpPWpGaD
Everolimus—Stomatitis—Colchicine—primary biliary cirrhosis	0.000297	0.00292	CcSEcCtD
Everolimus—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000295	0.0029	CcSEcCtD
Everolimus—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000295	0.0029	CcSEcCtD
Everolimus—Haematuria—Colchicine—primary biliary cirrhosis	0.00029	0.00286	CcSEcCtD
Everolimus—MTOR—Costimulation by the CD28 family—CTLA4—primary biliary cirrhosis	0.000287	0.00553	CbGpPWpGaD
Everolimus—Dysuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00282	CcSEcCtD
Everolimus—Dysuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00282	CcSEcCtD
Everolimus—CYP3A4—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.000285	0.0055	CbGpPWpGaD
Everolimus—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000285	0.00281	CcSEcCtD
Everolimus—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000285	0.00281	CcSEcCtD
Everolimus—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000283	0.00279	CcSEcCtD
Everolimus—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000283	0.00279	CcSEcCtD
Everolimus—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000277	0.00273	CcSEcCtD
Everolimus—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000277	0.00273	CcSEcCtD
Everolimus—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000275	0.00271	CcSEcCtD
Everolimus—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000275	0.00271	CcSEcCtD
Everolimus—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.000273	0.00269	CcSEcCtD
Everolimus—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000273	0.00269	CcSEcCtD
Everolimus—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.000273	0.00269	CcSEcCtD
Everolimus—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000273	0.00269	CcSEcCtD
Everolimus—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.000272	0.00268	CcSEcCtD
Everolimus—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.000269	0.00265	CcSEcCtD
Everolimus—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.000269	0.00265	CcSEcCtD
Everolimus—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000269	0.00265	CcSEcCtD
Everolimus—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000269	0.00265	CcSEcCtD
Everolimus—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000268	0.00264	CcSEcCtD
Everolimus—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000268	0.00264	CcSEcCtD
Everolimus—MTOR—Insulin Signaling—MAP3K14—primary biliary cirrhosis	0.000268	0.00516	CbGpPWpGaD
Everolimus—Jaundice—Chenodeoxycholic acid—primary biliary cirrhosis	0.000266	0.00262	CcSEcCtD
Everolimus—Jaundice—Ursodeoxycholic acid—primary biliary cirrhosis	0.000266	0.00262	CcSEcCtD
Everolimus—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000266	0.00262	CcSEcCtD
Everolimus—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000266	0.00262	CcSEcCtD
Everolimus—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000266	0.00262	CcSEcCtD
Everolimus—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000266	0.00262	CcSEcCtD
Everolimus—MTOR—epithelium—primary biliary cirrhosis	0.000264	0.201	CbGeAlD
Everolimus—MTOR—Interferon type I signaling pathways—RPS6KB1—primary biliary cirrhosis	0.000261	0.00503	CbGpPWpGaD
Everolimus—MTOR—ErbB Signaling Pathway—RPS6KB1—primary biliary cirrhosis	0.000261	0.00503	CbGpPWpGaD
Everolimus—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000261	0.00257	CcSEcCtD
Everolimus—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000261	0.00257	CcSEcCtD
Everolimus—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.000259	0.00255	CcSEcCtD
Everolimus—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.000259	0.00255	CcSEcCtD
Everolimus—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000258	0.00254	CcSEcCtD
Everolimus—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000258	0.00254	CcSEcCtD
Everolimus—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000256	0.00252	CcSEcCtD
Everolimus—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000256	0.00252	CcSEcCtD
Everolimus—Eye disorder—Colchicine—primary biliary cirrhosis	0.000255	0.00251	CcSEcCtD
Everolimus—MTOR—smooth muscle tissue—primary biliary cirrhosis	0.000254	0.194	CbGeAlD
Everolimus—FKBP1A—Spinal Cord Injury—IL4—primary biliary cirrhosis	0.000248	0.00478	CbGpPWpGaD
Everolimus—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000247	0.00243	CcSEcCtD
Everolimus—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000247	0.00243	CcSEcCtD
Everolimus—MTOR—mTOR signaling pathway—PPARGC1A—primary biliary cirrhosis	0.000246	0.00475	CbGpPWpGaD
Everolimus—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000246	0.00242	CcSEcCtD
Everolimus—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000246	0.00242	CcSEcCtD
Everolimus—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000246	0.00242	CcSEcCtD
Everolimus—MTOR—Oncostatin M Signaling Pathway—MMP3—primary biliary cirrhosis	0.000246	0.00474	CbGpPWpGaD
Everolimus—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000245	0.00242	CcSEcCtD
Everolimus—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000245	0.00242	CcSEcCtD
Everolimus—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000244	0.0024	CcSEcCtD
Everolimus—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000244	0.0024	CcSEcCtD
Everolimus—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000242	0.00239	CcSEcCtD
Everolimus—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000242	0.00239	CcSEcCtD
Everolimus—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000242	0.00238	CcSEcCtD
Everolimus—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000242	0.00238	CcSEcCtD
Everolimus—Alopecia—Colchicine—primary biliary cirrhosis	0.000241	0.00238	CcSEcCtD
Everolimus—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000241	0.00237	CcSEcCtD
Everolimus—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000241	0.00237	CcSEcCtD
Everolimus—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000241	0.00237	CcSEcCtD
Everolimus—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000241	0.00237	CcSEcCtD
Everolimus—MTOR—IL4-mediated signaling events—CD40LG—primary biliary cirrhosis	0.00024	0.00463	CbGpPWpGaD
Everolimus—MTOR—IL12-mediated signaling events—IL4—primary biliary cirrhosis	0.00024	0.00462	CbGpPWpGaD
Everolimus—Malnutrition—Colchicine—primary biliary cirrhosis	0.000238	0.00234	CcSEcCtD
Everolimus—FKBP1A—epithelium—primary biliary cirrhosis	0.000237	0.181	CbGeAlD
Everolimus—MTOR—IL4-mediated signaling events—IL4—primary biliary cirrhosis	0.000234	0.0045	CbGpPWpGaD
Everolimus—MTOR—IL4-mediated signaling events—RPS6KB1—primary biliary cirrhosis	0.000234	0.0045	CbGpPWpGaD
Everolimus—FKBP1A—TGF-beta Receptor Signaling—NFKB1—primary biliary cirrhosis	0.000233	0.0045	CbGpPWpGaD
Everolimus—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000229	0.00226	CcSEcCtD
Everolimus—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000229	0.00226	CcSEcCtD
Everolimus—Muscle spasms—Colchicine—primary biliary cirrhosis	0.000229	0.00225	CcSEcCtD
Everolimus—FKBP1A—smooth muscle tissue—primary biliary cirrhosis	0.000229	0.174	CbGeAlD
Everolimus—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000228	0.00224	CcSEcCtD
Everolimus—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000228	0.00224	CcSEcCtD
Everolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TAB1—primary biliary cirrhosis	0.000227	0.00437	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	0.000226	0.00437	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—COL1A1—primary biliary cirrhosis	0.000226	0.00436	CbGpPWpGaD
Everolimus—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000223	0.00219	CcSEcCtD
Everolimus—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000223	0.00219	CcSEcCtD
Everolimus—MTOR—TSH signaling pathway—RPS6KB1—primary biliary cirrhosis	0.000222	0.00428	CbGpPWpGaD
Everolimus—MTOR—mTOR signaling pathway—RPS6KB1—primary biliary cirrhosis	0.000222	0.00428	CbGpPWpGaD
Everolimus—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000222	0.00218	CcSEcCtD
Everolimus—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000222	0.00218	CcSEcCtD
Everolimus—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000221	0.00218	CcSEcCtD
Everolimus—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000221	0.00218	CcSEcCtD
Everolimus—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00217	CcSEcCtD
Everolimus—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00217	CcSEcCtD
Everolimus—Anaemia—Colchicine—primary biliary cirrhosis	0.00022	0.00216	CcSEcCtD
Everolimus—Angioedema—Colchicine—primary biliary cirrhosis	0.000217	0.00214	CcSEcCtD
Everolimus—MTOR—PI3K Cascade—RPS6KB1—primary biliary cirrhosis	0.000217	0.00418	CbGpPWpGaD
Everolimus—MTOR—Regulation of Telomerase—RPS6KB1—primary biliary cirrhosis	0.000217	0.00418	CbGpPWpGaD
Everolimus—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000217	0.00213	CcSEcCtD
Everolimus—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000217	0.00213	CcSEcCtD
Everolimus—MTOR—AMPK Signaling—RPS6KB1—primary biliary cirrhosis	0.000214	0.00413	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—ALPL—primary biliary cirrhosis	0.000214	0.00412	CbGpPWpGaD
Everolimus—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000214	0.0021	CcSEcCtD
Everolimus—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000214	0.0021	CcSEcCtD
Everolimus—Leukopenia—Colchicine—primary biliary cirrhosis	0.000213	0.0021	CcSEcCtD
Everolimus—MTOR—CDC42 signaling events—RPS6KB1—primary biliary cirrhosis	0.000212	0.00409	CbGpPWpGaD
Everolimus—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00021	0.00207	CcSEcCtD
Everolimus—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00021	0.00207	CcSEcCtD
Everolimus—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.00021	0.00405	CbGpPWpGaD
Everolimus—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000207	0.00203	CcSEcCtD
Everolimus—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000207	0.00203	CcSEcCtD
Everolimus—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.000205	0.00202	CcSEcCtD
Everolimus—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.000205	0.00202	CcSEcCtD
Everolimus—Arthralgia—Colchicine—primary biliary cirrhosis	0.000202	0.00199	CcSEcCtD
Everolimus—Myalgia—Colchicine—primary biliary cirrhosis	0.000202	0.00199	CcSEcCtD
Everolimus—MTOR—Leptin signaling pathway—RPS6KB1—primary biliary cirrhosis	0.000201	0.00387	CbGpPWpGaD
Everolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.0002	0.00385	CbGpPWpGaD
Everolimus—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000199	0.00383	CbGpPWpGaD
Everolimus—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000198	0.00195	CcSEcCtD
Everolimus—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000198	0.00195	CcSEcCtD
Everolimus—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000197	0.00194	CcSEcCtD
Everolimus—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000197	0.00194	CcSEcCtD
Everolimus—FKBP1A—Spinal Cord Injury—NOS2—primary biliary cirrhosis	0.000196	0.00377	CbGpPWpGaD
Everolimus—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000195	0.00192	CcSEcCtD
Everolimus—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000195	0.00192	CcSEcCtD
Everolimus—MTOR—Oncostatin M Signaling Pathway—HIF1A—primary biliary cirrhosis	0.000195	0.00376	CbGpPWpGaD
Everolimus—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.000193	0.0019	CcSEcCtD
Everolimus—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.000193	0.0019	CcSEcCtD
Everolimus—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000192	0.00189	CcSEcCtD
Everolimus—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000192	0.00189	CcSEcCtD
Everolimus—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000191	0.00188	CcSEcCtD
Everolimus—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000191	0.00188	CcSEcCtD
Everolimus—Shock—Colchicine—primary biliary cirrhosis	0.000191	0.00188	CcSEcCtD
Everolimus—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00019	0.00187	CcSEcCtD
Everolimus—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.00019	0.00187	CcSEcCtD
Everolimus—MTOR—IL12-mediated signaling events—NOS2—primary biliary cirrhosis	0.000189	0.00364	CbGpPWpGaD
Everolimus—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.000189	0.00186	CcSEcCtD
Everolimus—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.000189	0.00186	CcSEcCtD
Everolimus—Skin disorder—Colchicine—primary biliary cirrhosis	0.000188	0.00186	CcSEcCtD
Everolimus—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000188	0.00185	CcSEcCtD
Everolimus—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000188	0.00185	CcSEcCtD
Everolimus—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000186	0.00184	CcSEcCtD
Everolimus—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000186	0.00184	CcSEcCtD
Everolimus—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.000185	0.00182	CcSEcCtD
Everolimus—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.000185	0.00182	CcSEcCtD
Everolimus—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000184	0.00182	CcSEcCtD
Everolimus—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000184	0.00182	CcSEcCtD
Everolimus—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000182	0.00179	CcSEcCtD
Everolimus—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000182	0.00179	CcSEcCtD
Everolimus—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000182	0.00179	CcSEcCtD
Everolimus—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000182	0.00179	CcSEcCtD
Everolimus—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000182	0.00179	CcSEcCtD
Everolimus—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000182	0.00179	CcSEcCtD
Everolimus—MTOR—IRS-mediated signalling—RPS6KB1—primary biliary cirrhosis	0.000181	0.0035	CbGpPWpGaD
Everolimus—Hypotension—Colchicine—primary biliary cirrhosis	0.000181	0.00179	CcSEcCtD
Everolimus—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000181	0.00178	CcSEcCtD
Everolimus—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000181	0.00178	CcSEcCtD
Everolimus—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00018	0.00177	CcSEcCtD
Everolimus—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00018	0.00177	CcSEcCtD
Everolimus—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.000178	0.00175	CcSEcCtD
Everolimus—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.000178	0.00175	CcSEcCtD
Everolimus—MTOR—IL2 signaling events mediated by PI3K—NFKB1—primary biliary cirrhosis	0.000178	0.00342	CbGpPWpGaD
Everolimus—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.000177	0.00341	CbGpPWpGaD
Everolimus—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000177	0.00174	CcSEcCtD
Everolimus—MTOR—IRS-related events—RPS6KB1—primary biliary cirrhosis	0.000176	0.0034	CbGpPWpGaD
Everolimus—MTOR—IRS-related events triggered by IGF1R—RPS6KB1—primary biliary cirrhosis	0.000175	0.00337	CbGpPWpGaD
Everolimus—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000174	0.00172	CcSEcCtD
Everolimus—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000174	0.00172	CcSEcCtD
Everolimus—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000173	0.00171	CcSEcCtD
Everolimus—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000173	0.00171	CcSEcCtD
Everolimus—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000172	0.00169	CcSEcCtD
Everolimus—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000172	0.00169	CcSEcCtD
Everolimus—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000171	0.00168	CcSEcCtD
Everolimus—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000171	0.00168	CcSEcCtD
Everolimus—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000171	0.00168	CcSEcCtD
Everolimus—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000171	0.00168	CcSEcCtD
Everolimus—MTOR—IGF1R signaling cascade—RPS6KB1—primary biliary cirrhosis	0.00017	0.00328	CbGpPWpGaD
Everolimus—MTOR—Insulin receptor signalling cascade—RPS6KB1—primary biliary cirrhosis	0.00017	0.00328	CbGpPWpGaD
Everolimus—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00017	0.00168	CcSEcCtD
Everolimus—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00017	0.00168	CcSEcCtD
Everolimus—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000169	0.00167	CcSEcCtD
Everolimus—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000169	0.00167	CcSEcCtD
Everolimus—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000169	0.00166	CcSEcCtD
Everolimus—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000169	0.00166	CcSEcCtD
Everolimus—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000169	0.00166	CcSEcCtD
Everolimus—MTOR—Interferon type I signaling pathways—TYK2—primary biliary cirrhosis	0.000168	0.00325	CbGpPWpGaD
Everolimus—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000168	0.00165	CcSEcCtD
Everolimus—Fatigue—Colchicine—primary biliary cirrhosis	0.000167	0.00165	CcSEcCtD
Everolimus—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000166	0.00164	CcSEcCtD
Everolimus—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000166	0.00164	CcSEcCtD
Everolimus—MTOR—Costimulation by the CD28 family—CD80—primary biliary cirrhosis	0.000166	0.0032	CbGpPWpGaD
Everolimus—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000163	0.0016	CcSEcCtD
Everolimus—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000163	0.0016	CcSEcCtD
Everolimus—MTOR—Adaptive Immune System—ICAM3—primary biliary cirrhosis	0.00016	0.00309	CbGpPWpGaD
Everolimus—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000159	0.00156	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000159	0.00156	CcSEcCtD
Everolimus—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000159	0.00156	CcSEcCtD
Everolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—AGT—primary biliary cirrhosis	0.000158	0.00305	CbGpPWpGaD
Everolimus—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000158	0.00155	CcSEcCtD
Everolimus—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000158	0.00155	CcSEcCtD
Everolimus—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000157	0.00154	CcSEcCtD
Everolimus—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000157	0.00154	CcSEcCtD
Everolimus—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000155	0.00153	CcSEcCtD
Everolimus—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000155	0.00153	CcSEcCtD
Everolimus—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000155	0.00153	CcSEcCtD
Everolimus—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000155	0.00153	CcSEcCtD
Everolimus—MTOR—IL12-mediated signaling events—TYK2—primary biliary cirrhosis	0.000155	0.00298	CbGpPWpGaD
Everolimus—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000153	0.00151	CcSEcCtD
Everolimus—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000153	0.00151	CcSEcCtD
Everolimus—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000153	0.00151	CcSEcCtD
Everolimus—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000152	0.00149	CcSEcCtD
Everolimus—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000152	0.00149	CcSEcCtD
Everolimus—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000151	0.00148	CcSEcCtD
Everolimus—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000151	0.00148	CcSEcCtD
Everolimus—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00015	0.00148	CcSEcCtD
Everolimus—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00015	0.00148	CcSEcCtD
Everolimus—MTOR—liver—primary biliary cirrhosis	0.000149	0.114	CbGeAlD
Everolimus—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000149	0.00147	CcSEcCtD
Everolimus—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000149	0.00147	CcSEcCtD
Everolimus—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000149	0.00147	CcSEcCtD
Everolimus—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000149	0.00147	CcSEcCtD
Everolimus—MTOR—TSLP Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000147	0.00283	CbGpPWpGaD
Everolimus—MTOR—Oncostatin M Signaling Pathway—TYK2—primary biliary cirrhosis	0.000145	0.0028	CbGpPWpGaD
Everolimus—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000144	0.00141	CcSEcCtD
Everolimus—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000144	0.00141	CcSEcCtD
Everolimus—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000143	0.00141	CcSEcCtD
Everolimus—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000143	0.0014	CcSEcCtD
Everolimus—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000143	0.0014	CcSEcCtD
Everolimus—MTOR—Integrated Breast Cancer Pathway—TAB1—primary biliary cirrhosis	0.000142	0.00273	CbGpPWpGaD
Everolimus—MTOR—Signaling by Insulin receptor—RPS6KB1—primary biliary cirrhosis	0.000141	0.00273	CbGpPWpGaD
Everolimus—Asthenia—Colchicine—primary biliary cirrhosis	0.000139	0.00137	CcSEcCtD
Everolimus—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000138	0.00136	CcSEcCtD
Everolimus—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000138	0.00136	CcSEcCtD
Everolimus—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000138	0.00136	CcSEcCtD
Everolimus—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000138	0.00136	CcSEcCtD
Everolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—CD80—primary biliary cirrhosis	0.000137	0.00265	CbGpPWpGaD
Everolimus—FKBP1A—liver—primary biliary cirrhosis	0.000134	0.103	CbGeAlD
Everolimus—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000133	0.00131	CcSEcCtD
Everolimus—MTOR—Cardiac Hypertrophic Response—NFKB1—primary biliary cirrhosis	0.000129	0.00249	CbGpPWpGaD
Everolimus—MTOR—RANKL/RANK Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000129	0.00249	CbGpPWpGaD
Everolimus—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000128	0.00126	CcSEcCtD
Everolimus—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000128	0.00126	CcSEcCtD
Everolimus—FKBP1A—Spinal Cord Injury—MMP9—primary biliary cirrhosis	0.000126	0.00243	CbGpPWpGaD
Everolimus—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000125	0.00123	CcSEcCtD
Everolimus—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000125	0.00123	CcSEcCtD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—TAB1—primary biliary cirrhosis	0.000125	0.00241	CbGpPWpGaD
Everolimus—MTOR—PI-3K cascade—CD80—primary biliary cirrhosis	0.000124	0.00239	CbGpPWpGaD
Everolimus—Vomiting—Colchicine—primary biliary cirrhosis	0.000123	0.00121	CcSEcCtD
Everolimus—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000123	0.00121	CcSEcCtD
Everolimus—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000123	0.00121	CcSEcCtD
Everolimus—Rash—Colchicine—primary biliary cirrhosis	0.000122	0.0012	CcSEcCtD
Everolimus—Dermatitis—Colchicine—primary biliary cirrhosis	0.000122	0.0012	CcSEcCtD
Everolimus—Headache—Colchicine—primary biliary cirrhosis	0.000122	0.0012	CcSEcCtD
Everolimus—MTOR—PI3K/AKT activation—CD80—primary biliary cirrhosis	0.000121	0.00233	CbGpPWpGaD
Everolimus—MTOR—IL12-mediated signaling events—NFKB1—primary biliary cirrhosis	0.000121	0.00232	CbGpPWpGaD
Everolimus—MTOR—GAB1 signalosome—CD80—primary biliary cirrhosis	0.00012	0.00231	CbGpPWpGaD
Everolimus—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000119	0.00117	CcSEcCtD
Everolimus—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000119	0.00117	CcSEcCtD
Everolimus—MTOR—BDNF signaling pathway—RPS6KB1—primary biliary cirrhosis	0.000119	0.00229	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—CD79A—primary biliary cirrhosis	0.000118	0.00227	CbGpPWpGaD
Everolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—CD80—primary biliary cirrhosis	0.000117	0.00226	CbGpPWpGaD
Everolimus—MTOR—IRS-mediated signalling—TYK2—primary biliary cirrhosis	0.000117	0.00226	CbGpPWpGaD
Everolimus—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000117	0.00225	CbGpPWpGaD
Everolimus—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000115	0.00113	CcSEcCtD
Everolimus—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000115	0.00113	CcSEcCtD
Everolimus—Nausea—Colchicine—primary biliary cirrhosis	0.000115	0.00113	CcSEcCtD
Everolimus—MTOR—IRS-related events—TYK2—primary biliary cirrhosis	0.000114	0.0022	CbGpPWpGaD
Everolimus—MTOR—Oncostatin M Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000113	0.00218	CbGpPWpGaD
Everolimus—MTOR—IRS-related events triggered by IGF1R—TYK2—primary biliary cirrhosis	0.000113	0.00218	CbGpPWpGaD
Everolimus—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000111	0.00109	CcSEcCtD
Everolimus—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000111	0.00109	CcSEcCtD
Everolimus—MTOR—Insulin receptor signalling cascade—TYK2—primary biliary cirrhosis	0.00011	0.00212	CbGpPWpGaD
Everolimus—MTOR—IGF1R signaling cascade—TYK2—primary biliary cirrhosis	0.00011	0.00212	CbGpPWpGaD
Everolimus—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.00011	0.00108	CcSEcCtD
Everolimus—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.00011	0.00108	CcSEcCtD
Everolimus—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00011	0.00108	CcSEcCtD
Everolimus—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00011	0.00108	CcSEcCtD
Everolimus—MTOR—Insulin Signaling—RPS6KB1—primary biliary cirrhosis	0.000109	0.00211	CbGpPWpGaD
Everolimus—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000109	0.00108	CcSEcCtD
Everolimus—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000109	0.00108	CcSEcCtD
Everolimus—MTOR—Regulation of Telomerase—NFKB1—primary biliary cirrhosis	0.000109	0.0021	CbGpPWpGaD
Everolimus—MTOR—EGF/EGFR Signaling Pathway—RPS6KB1—primary biliary cirrhosis	0.000108	0.00209	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD3D—primary biliary cirrhosis	0.000106	0.00204	CbGpPWpGaD
Everolimus—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000104	0.00102	CcSEcCtD
Everolimus—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000104	0.00102	CcSEcCtD
Everolimus—MTOR—Leptin signaling pathway—NFKB1—primary biliary cirrhosis	0.000101	0.00194	CbGpPWpGaD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—TYK2—primary biliary cirrhosis	9.74e-05	0.00188	CbGpPWpGaD
Everolimus—MTOR—Immune System—ICAM3—primary biliary cirrhosis	9.73e-05	0.00188	CbGpPWpGaD
Everolimus—MTOR—CXCR4-mediated signaling events—MMP9—primary biliary cirrhosis	9.31e-05	0.0018	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—CD80—primary biliary cirrhosis	9.25e-05	0.00178	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—MAP3K14—primary biliary cirrhosis	9.21e-05	0.00178	CbGpPWpGaD
Everolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—primary biliary cirrhosis	9.21e-05	0.00178	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—TYK2—primary biliary cirrhosis	9.2e-05	0.00177	CbGpPWpGaD
Everolimus—MTOR—Signaling by Insulin receptor—TYK2—primary biliary cirrhosis	9.13e-05	0.00176	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—CD80—primary biliary cirrhosis	8.86e-05	0.00171	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—CD80—primary biliary cirrhosis	8.72e-05	0.00168	CbGpPWpGaD
Everolimus—MTOR—Immune System—SP100—primary biliary cirrhosis	8.67e-05	0.00167	CbGpPWpGaD
Everolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	8.49e-05	0.00164	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—ELMO1—primary biliary cirrhosis	8.35e-05	0.00161	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—CD80—primary biliary cirrhosis	8.32e-05	0.0016	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—CD80—primary biliary cirrhosis	8.28e-05	0.0016	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—CD80—primary biliary cirrhosis	8.24e-05	0.00159	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—CD80—primary biliary cirrhosis	8.2e-05	0.00158	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—CD80—primary biliary cirrhosis	8.08e-05	0.00156	CbGpPWpGaD
Everolimus—FKBP1A—Disease—ELMO1—primary biliary cirrhosis	7.98e-05	0.00154	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—TYK2—primary biliary cirrhosis	7.81e-05	0.00151	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—CD80—primary biliary cirrhosis	7.72e-05	0.00149	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—CD80—primary biliary cirrhosis	7.72e-05	0.00149	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—CD80—primary biliary cirrhosis	7.72e-05	0.00149	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—CD80—primary biliary cirrhosis	7.65e-05	0.00147	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—CD80—primary biliary cirrhosis	7.58e-05	0.00146	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—CD80—primary biliary cirrhosis	7.55e-05	0.00145	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—TYK2—primary biliary cirrhosis	7.48e-05	0.00144	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—TYK2—primary biliary cirrhosis	7.36e-05	0.00142	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—CD80—primary biliary cirrhosis	7.14e-05	0.00138	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—TYK2—primary biliary cirrhosis	7.03e-05	0.00135	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—TYK2—primary biliary cirrhosis	6.99e-05	0.00135	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—TYK2—primary biliary cirrhosis	6.96e-05	0.00134	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—TYK2—primary biliary cirrhosis	6.92e-05	0.00133	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CDH5—primary biliary cirrhosis	6.91e-05	0.00133	CbGpPWpGaD
Everolimus—FKBP1A—Disease—NUP210—primary biliary cirrhosis	6.84e-05	0.00132	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—CD80—primary biliary cirrhosis	6.83e-05	0.00132	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CXCR5—primary biliary cirrhosis	6.65e-05	0.00128	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—TYK2—primary biliary cirrhosis	6.51e-05	0.00126	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—TYK2—primary biliary cirrhosis	6.51e-05	0.00126	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—TYK2—primary biliary cirrhosis	6.51e-05	0.00126	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—TYK2—primary biliary cirrhosis	6.45e-05	0.00124	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD3D—primary biliary cirrhosis	6.42e-05	0.00124	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—TYK2—primary biliary cirrhosis	6.4e-05	0.00123	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—TYK2—primary biliary cirrhosis	6.37e-05	0.00123	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—HIF1A—primary biliary cirrhosis	6.35e-05	0.00122	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—MMP9—primary biliary cirrhosis	6.15e-05	0.00119	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CXCL9—primary biliary cirrhosis	6.04e-05	0.00116	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—NFKB1—primary biliary cirrhosis	5.99e-05	0.00115	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL7R—primary biliary cirrhosis	5.9e-05	0.00114	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—TYK2—primary biliary cirrhosis	5.77e-05	0.00111	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—NFKB1—primary biliary cirrhosis	5.76e-05	0.00111	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—ELMO1—primary biliary cirrhosis	5.59e-05	0.00108	CbGpPWpGaD
Everolimus—MTOR—Immune System—MAP3K14—primary biliary cirrhosis	5.59e-05	0.00108	CbGpPWpGaD
Everolimus—FKBP1A—Disease—GOT2—primary biliary cirrhosis	5.41e-05	0.00104	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—primary biliary cirrhosis	5.32e-05	0.00103	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—CD80—primary biliary cirrhosis	5.26e-05	0.00101	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NFKB1—primary biliary cirrhosis	5.07e-05	0.000978	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CTLA4—primary biliary cirrhosis	4.98e-05	0.000959	CbGpPWpGaD
Everolimus—MTOR—Immune System—ELMO1—primary biliary cirrhosis	4.86e-05	0.000938	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—TAB1—primary biliary cirrhosis	4.85e-05	0.000936	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD79A—primary biliary cirrhosis	4.75e-05	0.000915	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—NFKB1—primary biliary cirrhosis	4.7e-05	0.000906	CbGpPWpGaD
Everolimus—FKBP1A—Disease—GOT1—primary biliary cirrhosis	4.67e-05	0.0009	CbGpPWpGaD
Everolimus—MTOR—Disease—ELMO1—primary biliary cirrhosis	4.49e-05	0.000866	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—TYK2—primary biliary cirrhosis	4.44e-05	0.000855	CbGpPWpGaD
Everolimus—CYP3A4—liver—primary biliary cirrhosis	4.39e-05	0.0335	CbGeAlD
Everolimus—MTOR—Immune System—NUP210—primary biliary cirrhosis	4.17e-05	0.000803	CbGpPWpGaD
Everolimus—Tacrolimus—ALB—primary biliary cirrhosis	4.05e-05	1	CrCbGaD
Everolimus—MTOR—Signaling Pathways—CDH5—primary biliary cirrhosis	3.89e-05	0.000749	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD40LG—primary biliary cirrhosis	3.87e-05	0.000746	CbGpPWpGaD
Everolimus—MTOR—Disease—NUP210—primary biliary cirrhosis	3.85e-05	0.000742	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CXCR5—primary biliary cirrhosis	3.74e-05	0.000721	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—NFKB1—primary biliary cirrhosis	3.69e-05	0.000711	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—NFKB1—primary biliary cirrhosis	3.46e-05	0.000667	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	3.41e-05	0.000657	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CXCL9—primary biliary cirrhosis	3.4e-05	0.000655	CbGpPWpGaD
Everolimus—FKBP1A—Disease—HIF1A—primary biliary cirrhosis	3.25e-05	0.000626	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CXCL10—primary biliary cirrhosis	3.15e-05	0.000607	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ELMO1—primary biliary cirrhosis	3.14e-05	0.000606	CbGpPWpGaD
Everolimus—MTOR—Disease—GOT2—primary biliary cirrhosis	3.04e-05	0.000586	CbGpPWpGaD
Everolimus—MTOR—Immune System—CTLA4—primary biliary cirrhosis	3.02e-05	0.000582	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CD80—primary biliary cirrhosis	3e-05	0.000578	CbGpPWpGaD
Everolimus—FKBP1A—Disease—NOS2—primary biliary cirrhosis	2.95e-05	0.00057	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD79A—primary biliary cirrhosis	2.88e-05	0.000555	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD80—primary biliary cirrhosis	2.88e-05	0.000555	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MMP3—primary biliary cirrhosis	2.87e-05	0.000553	CbGpPWpGaD
Everolimus—FKBP1A—Disease—CD80—primary biliary cirrhosis	2.87e-05	0.000553	CbGpPWpGaD
Everolimus—MTOR—Immune System—TAB1—primary biliary cirrhosis	2.83e-05	0.000545	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCL5—primary biliary cirrhosis	2.71e-05	0.000522	CbGpPWpGaD
Everolimus—MTOR—Disease—GOT1—primary biliary cirrhosis	2.63e-05	0.000506	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	2.62e-05	0.000506	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—TYK2—primary biliary cirrhosis	2.53e-05	0.000488	CbGpPWpGaD
Everolimus—FKBP1A—Disease—TYK2—primary biliary cirrhosis	2.42e-05	0.000467	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	2.35e-05	0.000453	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD40LG—primary biliary cirrhosis	2.35e-05	0.000453	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.27e-05	0.000438	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—AGT—primary biliary cirrhosis	2.27e-05	0.000437	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CD80—primary biliary cirrhosis	2.01e-05	0.000387	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—NFKB1—primary biliary cirrhosis	1.97e-05	0.00038	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—NFKB1—primary biliary cirrhosis	1.89e-05	0.000365	CbGpPWpGaD
Everolimus—MTOR—Disease—HIF1A—primary biliary cirrhosis	1.83e-05	0.000352	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.77e-05	0.000341	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD80—primary biliary cirrhosis	1.75e-05	0.000337	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	1.7e-05	0.000327	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TYK2—primary biliary cirrhosis	1.69e-05	0.000327	CbGpPWpGaD
Everolimus—MTOR—Disease—NOS2—primary biliary cirrhosis	1.66e-05	0.00032	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MMP3—primary biliary cirrhosis	1.61e-05	0.000311	CbGpPWpGaD
Everolimus—MTOR—Disease—CD80—primary biliary cirrhosis	1.61e-05	0.000311	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCL5—primary biliary cirrhosis	1.52e-05	0.000294	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	1.51e-05	0.000292	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.48e-05	0.000285	CbGpPWpGaD
Everolimus—MTOR—Immune System—TYK2—primary biliary cirrhosis	1.47e-05	0.000284	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	1.42e-05	0.000274	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	1.42e-05	0.000274	CbGpPWpGaD
Everolimus—MTOR—Disease—TYK2—primary biliary cirrhosis	1.36e-05	0.000262	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MMP9—primary biliary cirrhosis	1.33e-05	0.000257	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.32e-05	0.000255	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.28e-05	0.000247	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—AGT—primary biliary cirrhosis	1.27e-05	0.000246	CbGpPWpGaD
Everolimus—MTOR—Immune System—NFKB1—primary biliary cirrhosis	1.15e-05	0.000221	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CD80—primary biliary cirrhosis	1.13e-05	0.000218	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TYK2—primary biliary cirrhosis	9.53e-06	0.000184	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	8.55e-06	0.000165	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	7.95e-06	0.000153	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MMP9—primary biliary cirrhosis	7.5e-06	0.000145	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NFKB1—primary biliary cirrhosis	7.43e-06	0.000143	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	6.82e-06	0.000131	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	6.76e-06	0.00013	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	5.83e-06	0.000112	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	5.83e-06	0.000112	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	5.19e-06	0.0001	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	4.04e-06	7.79e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	3.1e-06	5.98e-05	CbGpPWpGaD
